You can listen now to the latest episode from Oxford +, with George Robinson, founding partner of Oxford Investment Consultants.
George talks about the unique challenges of investing in early-stage tech and biotech spinouts from Oxford University and brings incredible perspective on the risks, rewards, and real work involved in turning academic research into successful companies.
Wild Bioscience, a University of Oxford spinout focused on climate-resilient crops, has scaled its operations at Milton Park following a £45 million ($60 million) Series A investment led by the Ellison Institute of Technology (EIT), with continued support from Oxford...
The Oxford Trust has appointed two new trustees to its board: Lily Elsner of Jack Fertility and Emily Howman of Aoraki Consulting. Lily Elsner is an entrepreneur with extensive experience in building and leading start-ups. As CEO and co-founder of Jack Fertility,...
On 7th April, our Managing Director Sarah Haywood had the opportunity to join a delegation from the Oxford to Cambridge Growth Corridor for a visit to Paris. The visit provided an opportunity to explore two very different incubator and accelerator locations within the...